J&J | JNJ - Przychody Ze Sprzedaży

Cena Akcji
242.13
Dzienna Zmiana
0.83 0.34%
Miesięcznie
-0.65%
Rocznie
62.84%
Q2 Prognozy TE
235.72




Obroty Zmiana Data
AbbVie USD 16.62B 840M 2025-12
Abbott USD 11.46B 90M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Baxter International USD 2.97B 130M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Biogen USD 2.28B 250M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
CONMED USD 373.2M 35.3M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Hologic USD 1.05B 0 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
J&J USD 24.6B 610M 2025-12
Medtronic USD 9B 39M 2026-01
Merck USD 16.4B 880M 2025-12
Merit Medical Systems USD 393.9M 9.7M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12
Zoetis USD 2.4B 0 2025-12